Loading...
Current evidence in support of the second-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor alectinib for the treatment of non-small cell lung cancer positive for ALK translocation
Na minha lista:
| Udgivet i: | J Thorac Dis |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5107442/ https://ncbi.nlm.nih.gov/pubmed/27867615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2016.10.82 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|